AG真人官方

STOCK TITAN

Mereo Biopharma SEC Filings

MREO NASDAQ

Welcome to our dedicated page for Mereo Biopharma SEC filings (Ticker: MREO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Tracking Mereo Biopharma鈥檚 clinical milestones鈥攚hether a pivotal setrusumab result or a new Ultragenyx payment鈥攎eans digging through dense disclosures that can span hundreds of pages. Financial professionals often need to find cash-runway data, partnership terms, or insider confidence indicators fast, yet Mereo Biopharma insider trading Form 4 transactions, R&D footnotes, and risk factors are scattered across multiple forms.

Stock Titan鈥檚 AI decodes every document the moment it lands on EDGAR. Need a Mereo Biopharma quarterly earnings report 10-Q filing? Our engine highlights trial spend and liquidity in seconds. Looking for Mereo Biopharma Form 4 insider transactions real-time? Instant alerts show you each trade. From 10-Ks to 8-Ks, you鈥檒l see Mereo Biopharma SEC filings explained simply, complete with plain-English summaries, peer comparisons, and red-flag detection鈥攑erfect for understanding Mereo Biopharma SEC documents with AI instead of wading through technical language.

Use our platform to dive straight into the details that move the stock: Mereo Biopharma earnings report filing analysis pinpoints phase-3 funding needs; Mereo Biopharma executive stock transactions Form 4 surfaces buying or selling before catalyst dates; Mereo Biopharma annual report 10-K simplified outlines royalty structures; Mereo Biopharma proxy statement executive compensation breaks down incentive alignment; and Mereo Biopharma 8-K material events explained gives you context around surprise capital raises or trial outcomes. AG真人官方-time updates, AI-powered summaries, and full coverage of every form mean you spend less time searching and more time making informed decisions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.21%
Tags
quarterly report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.21%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report

FAQ

What is the current stock price of Mereo Biopharma (MREO)?

The current stock price of Mereo Biopharma (MREO) is $1.66 as of August 12, 2025.

What is the market cap of Mereo Biopharma (MREO)?

The market cap of Mereo Biopharma (MREO) is approximately 243.3M.
Mereo Biopharma

NASDAQ:MREO

MREO Rankings

MREO Stock Data

243.27M
148.69M
0.96%
77.43%
6.19%
Biotechnology
Pharmaceutical Preparations
United Kingdom
LONDON